These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8782454)

  • 1. Clinical evidence of efficient tumor targeting based on single-chain Fv antibody selected from a combinatorial library.
    Begent RH; Verhaar MJ; Chester KA; Casey JL; Green AJ; Napier MP; Hope-Stone LD; Cushen N; Keep PA; Johnson CJ; Hawkins RE; Hilson AJ; Robson L
    Nat Med; 1996 Sep; 2(9):979-84. PubMed ID: 8782454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant anti-carcinoembryonic antigen antibodies for targeting cancer.
    Chester KA; Mayer A; Bhatia J; Robson L; Spencer DI; Cooke SP; Flynn AA; Sharma SK; Boxer G; Pedley RB; Begent RH
    Cancer Chemother Pharmacol; 2000; 46 Suppl():S8-12. PubMed ID: 10950140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial single-chain antibody fragments, specific for carcinoembryonic antigen.
    Ayala M; Dueñas M; Santos A; Vázquez J; Menéndez A; Silva A; Gavilondo JV
    Biotechniques; 1992 Nov; 13(5):790-9. PubMed ID: 1418981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor localization of anti-CEA single-chain Fvs: improved targeting by non-covalent dimers.
    Wu AM; Chen W; Raubitschek A; Williams LE; Neumaier M; Fischer R; Hu SZ; Odom-Maryon T; Wong JY; Shively JE
    Immunotechnology; 1996 Feb; 2(1):21-36. PubMed ID: 9373325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient construction of a diabody using a refolding system: anti-carcinoembryonic antigen recombinant antibody fragment.
    Asano R; Kudo T; Nishimura Y; Makabe K; Hayashi H; Suzuki M; Tsumoto K; Kumagai I
    J Biochem; 2002 Dec; 132(6):903-9. PubMed ID: 12473192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of a single chain anti-CEA antibody from the hybridoma cell line T84.66 using a modified colony-lift selection procedure to detect antigen-positive ScFv bacterial clones.
    Rodenburg CM; Mernaugh R; Bilbao G; Khazaeli MB
    Hybridoma; 1998 Feb; 17(1):1-8. PubMed ID: 9523232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production, purification and characterization of an anti-(carcinoembryonic antigen) recombinant single-chain Fv antibody fragment.
    Pérez L; Vázquez JE; Ayala M; Siccardi AG; Tresoldi E; de Lalla C; Gavilondo JV; Sidoli A
    Biotechnol Appl Biochem; 1996 Aug; 24(1):79-82. PubMed ID: 8756397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Numerical selection of optimal tumor imaging agents with application to engineered antibodies.
    Williams LE; Wu AM; Yazaki PJ; Liu A; Raubitschek AA; Shively JE; Wong JY
    Cancer Biother Radiopharm; 2001 Feb; 16(1):25-35. PubMed ID: 11279795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioimmunoguided surgery in colorectal cancer using a genetically engineered anti-CEA single-chain Fv antibody.
    Mayer A; Tsiompanou E; O'Malley D; Boxer GM; Bhatia J; Flynn AA; Chester KA; Davidson BR; Lewis AA; Winslet MC; Dhillon AP; Hilson AJ; Begent RH
    Clin Cancer Res; 2000 May; 6(5):1711-9. PubMed ID: 10815889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divalent forms of CC49 single-chain antibody constructs in Pichia pastoris: expression, purification, and characterization.
    Goel A; Beresford GW; Colcher D; Pavlinkova G; Booth BJ; Baranowska-Kortylewicz J; Batra SK
    J Biochem; 2000 May; 127(5):829-36. PubMed ID: 10788792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of fusion phage libraries displaying VH or single-chain Fv antibody fragments derived from the antibody repertoire of a vaccinated melanoma patient as a source of melanoma-specific targeting molecules.
    Cai X; Garen A
    Proc Natl Acad Sci U S A; 1997 Aug; 94(17):9261-6. PubMed ID: 9256470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tailoring the pharmacokinetics and positron emission tomography imaging properties of anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments.
    Kenanova V; Olafsen T; Crow DM; Sundaresan G; Subbarayan M; Carter NH; Ikle DN; Yazaki PJ; Chatziioannou AF; Gambhir SS; Williams LE; Shively JE; Colcher D; Raubitschek AA; Wu AM
    Cancer Res; 2005 Jan; 65(2):622-31. PubMed ID: 15695407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generating improved single-chain Fv molecules for tumor targeting.
    Adams GP; Schier R
    J Immunol Methods; 1999 Dec; 231(1-2):249-60. PubMed ID: 10648942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient display of scFv antibodies on bacteriophage lambda.
    Vaccaro P; Pavoni E; Monteriù G; Andrea P; Felici F; Minenkova O
    J Immunol Methods; 2006 Mar; 310(1-2):149-58. PubMed ID: 16497320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The in vivo characteristics of genetically engineered divalent and tetravalent single-chain antibody constructs.
    Wittel UA; Jain M; Goel A; Chauhan SC; Colcher D; Batra SK
    Nucl Med Biol; 2005 Feb; 32(2):157-64. PubMed ID: 15721761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single chain Fv derived from a filamentous phage library has distinct tumor targeting advantages over one derived from a hybridoma.
    Verhaar MJ; Chester KA; Keep PA; Robson L; Pedley RB; Boden JA; Hawkins RE; Begent RH
    Int J Cancer; 1995 May; 61(4):497-501. PubMed ID: 7759155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and identification of recombinant soluble single-chain variable fragment of monoclonal antibody MC3.
    He FT; Nie YZ; Chen BJ; Qiao TD; Fan DM; Li RF; Kang YS; Zhang Y
    World J Gastroenterol; 2002 Apr; 8(2):258-62. PubMed ID: 11925603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
    Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
    Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein.
    Xu X; Clarke P; Szalai G; Shively JE; Williams LE; Shyr Y; Shi E; Primus FJ
    Cancer Res; 2000 Aug; 60(16):4475-84. PubMed ID: 10969795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-chain antibodies in pancreatic cancer.
    Colcher D; Pavlinkova G; Beresford G; Booth BJ; Batra SK
    Ann N Y Acad Sci; 1999 Jun; 880():263-80. PubMed ID: 10415872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.